An inflammation-targeted nanoparticle with bacteria forced release of polymyxin B for pneumonia therapy.
Sign Up to like & getrecommendations! Published in 2022 at "Nanoscale"
DOI: 10.1039/d2nr02026b
Abstract: The epidemic of multidrug-resistant Gram-negative bacteria is an ever-growing global concern. Polymyxin B (PMB), a kind of "old fashioned" antibiotic, has been revived in clinical practice and mainly used as last-line antibiotics for otherwise untreatable… read more here.
Keywords: inflammation; nanoparticle; pneumonia; pmb ... See more keywords